Categories
C-IP2 News

[Archived Post] C-IP2 Spring 2024 Progress Report (December 2023-February 2024)

Greetings from C-IP2 Interim Executive Director Joshua A. Kresh I am pleased to report that our long-worked-on book, 5G and Beyond: Intellectual Property and Competition Policy in the Internet of Things, was published and is available from Cambridge University Press. We will also be hosting a launch event on Monday, April 15, from 12:20 – […]

Categories
C-IP2 News

[Archived Post] C-IP2 Winter 2023 Progress Report (September-November 2023)

Greetings from C-IP2 Interim Executive Director Joshua A. Kresh I am pleased to report a successful quarter and fall semester and am looking forward to several upcoming events this winter. We hosted the second meeting of our 2023-2024 Edison Fellowship in September and are looking forward to our third meeting in January and to paper […]

Categories
Artificial Intelligence Conferences Copyright Fair Use

[Archived Post] Panel 5A: Generative AI & Human Authorship (C-IP2 2023 Annual Fall Conference)

The following post comes from Jake L. Bryant, a student in the Intellectual Property Law LL.M. program at Scalia Law and a Research Assistant at C-IP2. On October 12th and 13th, the Center for Intellectual Property x Innovation Policy (C-IP2) hosted its 2023 Annual Fall Conference, this year titled First Sale: The Role of IP […]

Categories
Uncategorized

[Archived Post] Using Economic Models to Evaluate the Efficacy of U.S. Patent Examination

By William Matcham For the Center for Intellectual Property x Innovation Policy blog, in fulfillment of obligations for the Thomas Edison Innovation Law and Policy Fellowship Highlights: Policymakers frequently debate the effectiveness of the U.S. patent system – critics claim that problems arise from the ineffective patent application and examination process. We fill a large gap […]

Categories
Communications

[Archived Post] C-IP2 Fall 2023 Progress Report (June-August 2023)

Greetings from C-IP2 Interim Executive Director Joshua A. Kresh I am pleased to report that we had a productive summer and are looking forward to several upcoming events this fall. In June we ran the sixth iteration of the WIPO-U.S. Summer School on Intellectual Property, where we virtually welcomed students from around the world. Several […]

Categories
C-IP2 News

[Archived Post] C-IP2 2023 Summer Progress Report (March-May 2023)

Greetings from C-IP2 Interim Executive Director Joshua A. Kresh I am happy to provide our first progress report since I took over on May 25th as Interim Executive Director following Professor Seán O’Connor’s return to full-time research and teaching. With this Summer 2023 Progress Report, I am pleased to provide you with updates on what […]

Categories
Biotech Healthcare Patents Pharma

[Archived Post] Professors Erika Lietzan and Kristina Acri Argue That Current Data Do Not Support Evergreening Allegations

By Jack Ring In their forthcoming paper, Solutions Still Searching for a Problem: A Call for Relevant Data to Support “Evergreening” Allegations,[1] C-IP2 Senior Scholars Erika Lietzan of Mizzou Law and Kristina Acri of Colorado College call for relevant data to support evergreening allegations and accompanying policy proposals. “Evergreening” is often described as brand drug […]

Categories
Copyright

[Archived Post] For You and Me or Private Property?: Evaluating the Copyright Claim in Woody Guthrie’s “This Land Is Your Land”

By Jason Lee Guthrie For the Center for Intellectual Property x Innovation Policy blog, in fulfillment of obligations for the Thomas Edison Innovation Law and Policy Fellowship In early 1940, Woody Guthrie was on the road to New York City, and he was tired. Tired of traveling. Tired of the cold. Tired of having to […]

Categories
Pharma

[Archived Post] C-IP2 Statement on Interactions between Courts and the FDA

Courts have recently questioned Food and Drug Administration (FDA) determinations. The FDA is the administrative agency whose job is to evaluate scientific data to determine if a drug is safe and effective enough to be approved, and post-approval, to continue to evaluate such data to determine if a drug should remain available.   Generally, the most […]

Categories
Copyright Infringement Journalism

[Archived Post] Trump Interview Lawsuit Exposes Uncertainty in a Corner of Copyright Law

Will Donald Trump’s lawsuit against Bob Woodward and publisher Simon & Schuster[1] finally resolve the question of who owns the copyright over interviews? While the complaint has other challenges, it calls out a surprisingly muddled and unresolved area of copyright law. One might assume that the copyright ownership of interviews is a settled question. But […]